Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Empagliflozin alleviates endoplasmic reticulum stress and augments autophagy in rotenone-induced Parkinson's disease in rats: Targeting the GRP78/PERK/eIF2α/CHOP pathway and miR-211-5p
Tarek K. Motawi, Rawan H. Al-Kady, Sahar M. Abdelraouf, et al.
Chemico-Biological Interactions (2022) Vol. 362, pp. 110002-110002
Closed Access | Times Cited: 50

Showing 1-25 of 50 citing articles:

Antidiabetic agents as a novel treatment for Alzheimer’s and Parkinson’s disease
Joseph Nowell, Eleanor G Blunt, Dhruv Gupta, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101979-101979
Open Access | Times Cited: 82
Endoplasmic reticulum stress and therapeutic strategies in metabolic, neurodegenerative diseases and cancer
S. C. Yuan, Dan She, Shangming Jiang, et al.
Molecular Medicine (2024) Vol. 30, Iss. 1
Open Access | Times Cited: 37
Effects of Sodium-Glucose Cotransporter 2 Inhibitors on Nervous System Disorders: A Systematic Review and Meta-Analysis
Bo Xu, Mingxia Yang, Shaoqian Li, et al.
Annals of Pharmacotherapy (2025)
Closed Access | Times Cited: 2
Empagliflozin Ameliorates Bleomycin-Induced Pulmonary Fibrosis in Rats by Modulating Sesn2/AMPK/Nrf2 Signaling and Targeting Ferroptosis and Autophagy
Hemat El‐Sayed El‐Horany, Marwa Mohamed Atef, Muhammad Tarek Abdel Ghafar, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9481-9481
Open Access | Times Cited: 34
ncRNAs and their impact on dopaminergic neurons: Autophagy pathways in Parkinson's disease
Riya Thapa, Ehssan Moglad, Muhammad Afzal, et al.
Ageing Research Reviews (2024) Vol. 98, pp. 102327-102327
Closed Access | Times Cited: 14
The microRNA-211-5p/P2RX7/ERK/GPX4 axis regulates epilepsy-associated neuronal ferroptosis and oxidative stress
Xueying Li, Pusheng Quan, Yao Si, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 11
MicroRNAs in Parkinson’s disease: From pathogenesis to diagnostics and therapeutic strategies
Dongying Zheng, Jibing Chween
Neuroscience (2025)
Closed Access | Times Cited: 1
Empagliflozin repurposing in Parkinson’s disease; modulation of oxidative stress, neuroinflammation, AMPK/SIRT-1/PGC-1α, and wnt/β-catenin pathways
Noha Nabil Mohammed, Mariane G. Tadros, Mina Y. George
Inflammopharmacology (2023) Vol. 32, Iss. 1, pp. 777-794
Open Access | Times Cited: 20
Apigenin Attenuates Hippocampal Microglial Activation and Restores Cognitive Function in Methotrexate-Treated Rats: Targeting the miR-15a/ROCK-1/ERK1/2 Pathway
Mohamed Taha, Omar Mohsen Eldemerdash, Ismail Mohamed Elshaffei, et al.
Molecular Neurobiology (2023) Vol. 60, Iss. 7, pp. 3770-3787
Open Access | Times Cited: 19
Dexmedetomidine Attenuates Methotrexate-Induced Neurotoxicity and Memory Deficits in Rats through Improving Hippocampal Neurogenesis: The Role of miR-15a/ROCK-1/ERK1/2/CREB/BDNF Pathway Modulation
Mohamed Taha, Omar Mohsen Eldemerdash, Ismail Mohamed Elshaffei, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 1, pp. 766-766
Open Access | Times Cited: 16
Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review)
Zhenwang Ma, Hao Liang, Bingcheng Hu, et al.
International Journal of Molecular Medicine (2023) Vol. 51, Iss. 6
Open Access | Times Cited: 11
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
Giuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2993-2993
Open Access | Times Cited: 11
Strategies targeting endoplasmic reticulum stress to improve Parkinson’s disease
Danni Wang, Shuhui Qu, Zaijun Zhang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 11
Acrylamide Induces Antiapoptotic Autophagy and Apoptosis by Activating PERK Pathway in SH-SY5Y Cells
Yiqi Wang, Ying Liu, Xing Zhang, et al.
Toxics (2025) Vol. 13, Iss. 1, pp. 41-41
Open Access
Neuroprotective effects of empagliflozin against scopolamine-induced memory impairment and oxidative stress in rats
Mahdieh Anoush, Neda Taghaddosi, Zahra Bokaei Hosseini, et al.
IBRO Neuroscience Reports (2025) Vol. 18, pp. 163-170
Open Access
Association of serum and local GRP78 and CHOP expressions with disease progression in patients with non-traumatic osteonecrosis of femoral head
Peng Zhang, Qing-He Ye, Wenxiu Zhu, et al.
Journal of Orthopaedic Surgery and Research (2025) Vol. 20, Iss. 1
Open Access
Study on the mechanism of Dexmedetomidine’s effect on postoperative cognitive dysfunction in elderly people
Yao Cai, Yu Fan, Wei Wu, et al.
Frontiers in Physiology (2025) Vol. 16
Open Access
The potential neuroprotective effect of empagliflozin against depressive-like behavior induced by chronic unpredictable mild stress in rats: Involvement of NLRP3 inflammasome
Marwa A. Ali, Haidy E. Michel, Esther T. Menze, et al.
European Journal of Pharmacology (2025), pp. 177525-177525
Closed Access
Vitamin D and canagliflozin combination alleviates Parkinson’s disease in rats through modulation of RAC1/NF-κB/Nrf2 interaction
S Rizk, Eman Ali, Alzahraa A. M. Sheref, et al.
Immunopharmacology and Immunotoxicology (2025), pp. 1-17
Closed Access
Parkinson’s Disease: The Neurodegenerative Enigma Under the “Undercurrent” of Endoplasmic Reticulum Stress
Xiangrui Kong, Tingting Liu, Jianshe Wei
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 7, pp. 3367-3367
Open Access
Luteolin mitigates doxorubicin-induced hepatotoxicity and neurotoxicity: modulating the liver–brain axis via IRE1α/GRP78/ATF6 endoplasmic reticulum stress pathways and miRNA-199a-5p expression
Rasha D. Abdrabou, Rania M. Salama, Reem N. El‐Naga, et al.
Future Journal of Pharmaceutical Sciences (2025) Vol. 11, Iss. 1
Open Access
The role of retroelements in Parkinson’s disease development
Р. Н. Мустафин
Vavilov Journal of Genetics and Breeding (2025) Vol. 29, Iss. 2, pp. 290-300
Open Access
Targeting unfolded protein response reverts ER stress and ER Ca2+ homeostasis in cardiomyocytes expressing the pathogenic variant of Lamin A/C R321X
Giusy Pietrafesa, Roberta De Zio, Simona Scorza, et al.
Journal of Translational Medicine (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 10
Antidiabetic drugs in Parkinson’s disease
Yoshajandith Aguirre-Vidal, Sergio Montes, Ana Carolina Mota-López, et al.
Clinical Parkinsonism & Related Disorders (2024) Vol. 11, pp. 100265-100265
Open Access | Times Cited: 3
Repaglinide Elicits a Neuroprotective Effect in Rotenone-Induced Parkinson’s Disease in Rats: Emphasis on Targeting the DREAM-ER Stress BiP/ATF6/CHOP Trajectory and Activation of Mitophagy
Tarek K. Motawi, Rawan H. Al-Kady, Mahmoud A. Senousy, et al.
ACS Chemical Neuroscience (2022) Vol. 14, Iss. 1, pp. 180-194
Closed Access | Times Cited: 15
Page 1 - Next Page

Scroll to top